Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levosimendan Pretreatment for Weaning From CPB in CABG
NCT00130871Phase 2Completed
- Sponsor
- Orion Corporation
- Start
- Jan 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of levosimendan in coronary heart disease (CHD), heart failure (HF), sponsored by Orion Corporation. Started Jan 2004; status: completed.
02
Drugs
levosimendan
03
Conditions
coronary heart disease (CHD)heart failure (HF)
Beyond the preview
Go deeper on NCT00130871.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00130871.